Arcturus Therapeutics Holdings Inc.
ARCTNasdaqCIK 1768224HealthcareFiscal year ends Dec 31
Reports and events: 141 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-2316:11 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193805-26-001277 |
| 2026-08-2506:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193805-26-001130 |
| 2026-08-0616:19 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-338090 |
| 2026-08-0616:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193805-26-001039 |
| 2026-07-0207:05 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193805-26-000910 |
| 2026-06-0517:20 ET | 8-K | 5.07 Shareholder vote results | 0001193805-26-000770 |
| 2026-05-0716:14 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-211943 |
| 2026-05-0716:08 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193805-26-000573 |
| 2026-04-2416:05 ET | DEF 14A | Proxy statementPeriod 2026-06-05 | 0001193805-26-000507 |
| 2026-03-0316:34 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-088391 |
| 2026-03-0316:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193805-26-000214 |
| 2025-12-1508:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193805-25-001734 |
| 2025-11-1206:25 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-275758 |
| 2025-11-1016:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193805-25-001555 |
| 2025-10-2207:50 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193805-25-001499 |
| 2025-09-2606:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193805-25-001368 |
| 2025-08-2906:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193805-25-001247 |
| 2025-08-1116:14 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-106560 |
| 2025-08-1116:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193805-25-001175 |
| 2025-06-3016:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193805-25-000946 |
| 2025-06-0616:05 ET | 8-K | 5.07 Shareholder vote results | 0001193805-25-000820 |
| 2025-05-1216:11 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-069210 |
| 2025-05-1216:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193805-25-000630 |
| 2025-04-2517:15 ET | DEF 14A | Proxy statementPeriod 2025-06-06 | 0001193805-25-000561 |
| 2025-03-0616:39 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-034787 |
| 2025-03-0616:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193805-25-000275 |
| 2024-11-0716:58 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-123469 |
| 2024-11-0716:25 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193805-24-001318 |
| 2024-08-1307:54 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193805-24-001023 |
| 2024-08-0516:50 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-090905 |
| 2024-08-0516:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193805-24-000990 |
| 2024-06-2416:07 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193805-24-000842 |
| 2024-06-1416:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193805-24-000806 |
| 2024-05-0816:17 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-055702 |
| 2024-05-0816:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193805-24-000614 |
| 2024-04-2916:05 ET | DEF 14A | Proxy statementPeriod 2024-06-14 | 0001193805-24-000574 |
| 2024-04-0517:00 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001193805-24-000505 |
| 2024-03-1906:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193805-24-000392 |
| 2024-03-1409:09 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-031156 |
| 2024-03-1409:05 ET | 8-K/A | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193805-24-000364 |
| 2024-03-0716:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193805-24-000335 |
| 2024-02-2316:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193805-24-000264 |
| 2023-11-1416:34 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000950170-23-063778 |
| 2023-11-1416:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193805-23-001493 |
| 2023-09-2616:06 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193805-23-001328 |
| 2023-08-1416:06 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193805-23-001174 |
| 2023-08-0717:02 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000950170-23-039149 |
| 2023-08-0716:23 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193805-23-001112 |
| 2023-07-1407:53 ET | 8-K | 7.01 Regulation FD disclosure | 0001193805-23-000984 |
| 2023-06-3008:28 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193805-23-000929 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 06:06 ET. Listed shows no prices and gives no investment advice.